Comparing Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients

A Phase 2, Randomized, Double-blind, Parallel, Placebo-controlled, Multi-center Study to Compare Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients

Multi-center Study to Compare Efficacy and Safety between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients during 7 days.

Inclusion Criteria:

• Subjects who have ability to comprehend the contents of study and before participating in trial and have willingness to sign of informed consent in writing
• 20≤ age ≤60
• A patient has symptom of acute low back pain
• 4≤ VAS

Exclusion Criteria:

• Subjects who cannot prohibit anti-inflammatory drug, painkiller or muscle relaxants during clinical trial
• Chronic rheumatoid arthritis patients
• Patients having a medical history of hypersensitivity to Eperisone Hydrochloride
• Subject having a hereditary problem such as galactose intolerance, Lapp lactase deficiency, or glucose galatose malabsorption
• Participation in other studies before 60 days of first dosing
• Female patients having positive pregnancy test, lactating women,planning pregnancy during clinical trial
• Inadequate subject for the clinical trial by the investigator's decision